What This Means for Employers These two stories together tell a larger tale: the GLP-1 market is being contested on multiple fronts by manufacturers seeking to control distribution, by PBMs defending their role, and by consumer platforms navigating regulatory and legal pressures
Improved Blood Sugar Levels: These medications help control blood sugar levels, reducing the risk of diabetes-related complications
Characterization of the molecular mode of action of the sulfonylurea, glimepiride, at beta-cells
Recently, the SELECT trial demonstrated significant reductions in cardiovascular events, proving it does more than just shrink waistlines
Earlier this month the federal court cases were centralized in Philadelphia for efficiency
Molecular dissection of reactive astrogliosis and glial scar formation